Prevalence of Sleep-disordered Breathing in Patients With a Newly Diagnosed Non Small Cell Lung Cancer

Overview

There is a possible implication of sleep apnea syndrome via night-time intermittent hypoxemia in perturbation of quality of life and tumour progression to patients with a bronchial cancer. The aim of the study is to evaluate this possibility with the help of a night record of sleep and quality of life questionnaires.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Diagnostic
    • Masking: None (Open Label)
  • Study Primary Completion Date: November 2018

Detailed Description

There is a possible implication of sleep apnea syndrome via night-time intermittent hypoxemia in perturbation of quality of life and tumour progression to patients with a bronchial cancer. Enrollment 1200 patients This wide sample is expected to respond to the main and secondary objectives of the study

Interventions

  • Device: With and without SDB
    • Screening of sleep-disordered breathing (SDB)

Arms, Groups and Cohorts

  • Other: With and without SDB
    • comparison of patients with and without sleep-disordered breathing

Clinical Trial Outcome Measures

Primary Measures

  • Oxygen desaturation index
    • Time Frame: Between day 1 and day 15
    • RECORDING BY POLYGRAPHY DEVICE between day 1 and day 15 after enrollment

Participating in This Clinical Trial

Inclusion Criteria

  • patients with NSCLC undergoing diagnostic – Performance status 0,1,2 Exclusion Criteria:

  • >75 years – OSA known and in the last 12 months treated PS >2 – Patients under a long-term oxygen therapy – persons deprived of liberty by judicial decision. – <18 years

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 75 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Angers
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.